Holdings of Prosight Management, LP
41 declared positions · as of Mar 31, 2026
Original filing · Ten largest lines: 72.1 % of the equity sleeve
Sector breakdown
- Health care 14.5 %
- Technology 2.9 %
- Unattributed 82.7 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
The quoted currency of each line, as declared.
Country breakdown
- US 89.1 %
- BE 8.7 %
- FR 2.2 %
Shares computed on the equity sleeve.
| Country | Lines | Value | Share |
|---|
| US | 39 | 474M $ | 89.07 % |
| BE | 1 | 46.5M $ | 8.74 % |
| FR | 1 | 11.7M $ | 2.20 % |
Positions
| Company | Shares | Value | Weight |
|---|
| Nektar Therapeutics | 735,000 | 52.9M $ | |
| Boston Scientific Corp | 795,547 | 49.9M $ | |
| Janux Therapeutics Inc | 3,550,000 | 49.3M $ | |
| PROCEPT BIOROBOTICS CORP | 1,945,000 | 48.6M $ | |
| Galapagos NV | 1,550,000 | 46.5M $ | |
| GeneDx Holdings Corp | 523,463 | 33.6M $ | |
| Shattuck Labs Inc | 5,004,439 | 32.2M $ | |
| Kura Oncology Inc | 3,356,700 | 27.3M $ | |
| Alnylam Pharmaceuticals Inc | 76,000 | 25.1M $ | |
| Syndax Pharmaceuticals Inc | 770,000 | 18M $ | |
| Veeva Systems Inc | 86,480 | 15.2M $ | |
| Zymeworks Inc | 539,049 | 13.5M $ | |
| Crinetics Pharmaceuticals Inc | 350,000 | 12.7M $ | |
| Abivax SA | 105,000 | 11.7M $ | |
| Concentra Group Holdings Parent Inc | 505,822 | 10.8M $ | |
| Terns Pharmaceuticals Inc | 202,300 | 10.7M $ | |
| Phreesia Inc | 1,100,000 | 9.2M $ | |
| OnKure Therapeutics Inc | 2,154,381 | 8.9M $ | |
| Corbus Pharmaceuticals Holdings Inc | 697,108 | 6.5M $ | |
| Schrodinger Inc/United States | 510,578 | 5.8M $ | |
| Emergent BioSolutions Inc | 639,118 | 5.3M $ | |
| OrthoPediatrics Corp | 302,399 | 4.8M $ | |
| Immunovant Inc | 175,825 | 4.4M $ | |
| ICU Medical Inc | 27,450 | 3.5M $ | |
| Tectonic Therapeutic Inc | 79,872 | 2.5M $ | |
| Rocket Pharmaceuticals Inc | 683,856 | 2.4M $ | |
| Upstream Bio Inc | 241,123 | 2.2M $ | |
| Pliant Therapeutics Inc | 1,667,600 | 2.1M $ | |
| Omeros Corp | 174,800 | 1.8M $ | |
| Intuitive Surgical Inc | 4,000 | 1.8M $ | |
| AN2 Therapeutics Inc | 515,754 | 1.8M $ | |
| Adicet Bio Inc | 250,244 | 1.7M $ | |
| REGENXBIO Inc | 200,000 | 1.7M $ | |
| Coya Therapeutics Inc | 420,360 | 1.7M $ | |
| Viking Therapeutics Inc | 45,000 | 1.5M $ | |
| IRhythm Holdings Inc | 10,000 | 1.2M $ | |
| TrueBlue Inc | 249,107 | 974K $ | |
| Immuneering Corp | 123,409 | 650.4K $ | |
| Palvella Therapeutics Inc | 5,000 | 623.3K $ | |
| REIN THERAPEUTICS INC | 411,600 | 535.1K $ | |
| TransMedics Group Inc | 5,000 | 497.1K $ | |